Welcome to Helix Talk, a podcast presented by the Rosalm Franklin University College of Pharmacy.

This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics.

We're hoping that our real-life clinical pearls and discussions will help you stay up to date

and improve your pharmacy knowledge.

This is an educational production copyright Rosalind Franklin University of Medicine and Science.

This podcast contains general information for educational purposes only. This is not professional advice and should not be used in lieu of obtaining advice from a qualified healthcare provider.

And now, on to the show.

Welcome to Helix Talk episode 16. I'm your co-host Dr. Kane.

I'm Dr. Schumann.

I'm Dr. Patel.

I'm Dr. LaHorsi.

And today we're talking about three of the newer agents, FDA approved for diabetes.

So we're going to review diabetes kind of as an overview, but really focus on some of these

newer drug classes that have come out onto the market.

I am really excited to talk about them.

So just briefly, overviewing.

So the two main accrediting body who produce guidelines are ADA, American Diabetes Association

and AACE, which is the American Association of Clinical Endocrinologist.

AASD guidelines don't get updated very often, but ADA is keeping up with this every year.

So the most recent guidelines we have is 2014.

And that's pretty impressive if you think about it.

Every year for an updated guideline, that's pretty aggressive but also very admirable.

...